Induction of human cytomegalovirus (HCMV)-glycoprotein B (gB)-specific neutralizing antibody and phosphoprotein 65 (pp65)-specific cytotoxic T lymphocyte responses by naked DNA immunization

被引:44
作者
Endresz, V
Kari, L
Berencsi, K
Kari, C
Gyulai, Z
Jeney, C
Pincus, S
Rodeck, U
Méric, C
Plotkin, SA
Gönczöl, E
机构
[1] Wistar Inst Anat & Biol, Philadelphia, PA 19104 USA
[2] Albert Szent Gyorgyi Med Univ, Dept Microbiol, Szeged, Hungary
[3] Virogenet Corp, Troy, NY 12180 USA
[4] Pasteur Merieux Connaught, F-69280 Marcy Letoile, France
[5] Pasteur Merieux Connaught, F-92430 Marnes La Coquette, France
关键词
HCMV; antibody; CTL; DNA immunization;
D O I
10.1016/S0264-410X(98)00145-5
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Plasmids expressing the human cytomegalovirus (HCMV) glycoprotein B (gB) (UL55) or phosphoprotein 65 (pp65) (UL83) were constructed and evaluated for their ability to induce immune responses in mice. The full-length gB as well as a truncated form expressing amino acids 1-680 of gB, and lacking the fragment encoding amino acids 681-907 including the transmembrane domain of gB (gB680) were evaluated. Immunization of mice with plasmids coding for gB or gB680 induced ELISA and neutralizing antibodies, with the highest titres in mice immunized with the gB680 plasmid, Mice immunized with the gB plasmid predominantly produced IgG2a gB-specific antibody, while the gB680 plasmid raised mostly IgG1 anti-gB antibody. Mice immunized with the pp65 plasmid developed pp65-specific cytotoxic T lymphocytes (CTL) and ELISA antibodies. Immunization with a mixture of both gB and pp65 plasmids raised antibodies to both proteins and pp65-specific CTL, indicating a lack of interference between these two plasmids. These results suggest that DNA immunization is a useful approach for vaccination against HCMV disease. (C) 1998 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:50 / 58
页数:9
相关论文
共 60 条
[1]  
Armas JCG, 1996, J VIROL, V70, P7921
[2]   A MAJOR NEUTRALIZING DOMAIN MAPS WITHIN THE CARBOXYL-TERMINAL HALF OF THE CLEAVED CYTOMEGALOVIRUS-B GLYCOPROTEIN [J].
BANKS, T ;
HUO, B ;
KOUSOULAS, K ;
SPAETE, R ;
PACHL, C ;
PEREIRA, L .
JOURNAL OF GENERAL VIROLOGY, 1989, 70 :979-985
[3]   MURINE CYTOTOXIC T-CELL RESPONSE SPECIFIC FOR HUMAN CYTOMEGALOVIRUS GLYCOPROTEIN-B (GB) INDUCED BY ADENOVIRUS AND VACCINIA VIRUS RECOMBINANTS EXPRESSING GB [J].
BERENCSI, K ;
RANDO, RF ;
DETAISNE, C ;
PAOLETTI, E ;
PLOTKIN, SA ;
GONCZOL, E .
JOURNAL OF GENERAL VIROLOGY, 1993, 74 :2507-2512
[4]  
BERENCSI K, PROGR CYTOMEGALOVIRU, P191
[5]  
BERENCSI K, 1997, IN PRESS CELL ADHESI
[6]   DNA immunization against experimental genital herpes simplex virus infection [J].
Bourne, N ;
Stanberry, LR ;
Bernstein, DI ;
Lew, D .
JOURNAL OF INFECTIOUS DISEASES, 1996, 173 (04) :800-807
[7]   FORMULATION OF AN IMMUNOGENIC HUMAN CYTOMEGALOVIRUS VACCINE - RESPONSES IN MICE [J].
BRITT, W ;
FAY, J ;
SEALS, J ;
KENSIL, C .
JOURNAL OF INFECTIOUS DISEASES, 1995, 171 (01) :18-25
[8]   CELL-SURFACE EXPRESSION OF HUMAN CYTOMEGALOVIRUS (HCMV) GP55-116 (GB) - USE OF HCMV-RECOMBINANT VACCINIA VIRUS-INFECTED CELLS IN ANALYSIS OF THE HUMAN NEUTRALIZING ANTIBODY-RESPONSE [J].
BRITT, WJ ;
VUGLER, L ;
BUTFILOSKI, EJ ;
STEPHENS, EB .
JOURNAL OF VIROLOGY, 1990, 64 (03) :1079-1085
[10]  
BRITT WJ, VIROLOGY, P2493